Caroline S. de Freitas

Author

Also Known As

Caroline S. Freitas, Caroline Freitas, Caroline S de Freitas, Caroline S. De Freitas, Caroline S. Freitas, Caroline S. de Freitas, Caroline Souza de Freitas

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Fundação Oswaldo Cruz Universidade Federal do Rio de Janeiro D’Or Institute for Research and Education Universidade Iguaçu Instituto Evandro Chagas

About

Caroline S. de Freitas is an author at Fundação Oswaldo Cruz specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	340
2	Engineering	1	1	34
3	Natural Sciences	1	1	28
4	Biochemistry	1	1	34
5	Biomolecular Engineering	1	1	34

Caroline S. de Freitas

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators Suelen da Silva Gomes Dias, Vinícius Cardoso Soares, André C. Ferreira, PLoS Pathogens	2020	298
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes André C. Ferreira, Vinícius Cardoso Soares, Isaclaudia G. Azevedo-Quintanilha, Cell Death Discovery	2021	270
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication Carolina Q. Sacramento, Gabrielle R. de Melo, Caroline S. de Freitas, Scientific Reports	2017	236
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production Natalia Fintelman‐Rodrigues, Carolina Q. Sacramento, Carlyle Ribeiro Lima, Antimicrobial Agents and Chemotherapy	2020	138
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo Caroline S. de Freitas, Luiza M. Higa, Carolina Q. Sacramento, PLoS neglected tropical diseases	2019	119
<i>In vitro</i> antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19 Carolina Q. Sacramento, Natalia Fintelman‐Rodrigues, Jairo R. Temerozo, Journal of Antimicrobial Chemotherapy	2021	98
Beyond Members of the <i>Flaviviridae</i> Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication André C. Ferreira, Patrícia A. Reis, Caroline S. de Freitas, Antimicrobial Agents and Chemotherapy	2018	93
Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production Natalia Fintelman‐Rodrigues, Carolina Q. Sacramento, Carlyle Ribeiro Lima, ImmunologyImmunotherapeuticsSars-cov-2 ReplicationAntiviral DrugCovid-19	2020	69
2,8-bis(trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine Giselle Barbosa-Lima, Adriana Marques Moraes, Adriele da Silva Araújo, European Journal of Medicinal Chemistry MedicineAntiviral Drug DevelopmentAntiviral TherapyVirologyMicrobiology	2016	57
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts Lívia Teixeira, Jairo R. Temerozo, Filipe S. Pereira‐Dutra, Frontiers in Immunology	2022	52

Page 1